Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials-Reference-Cited by-同舟云学术

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials

Published:2017-12-30 Issue:8 Volume:66 Page:1164-1172
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Plennevaux Eric¹,Moureau Annick²,Arredondo-García José L³,Villar Luis⁴,Pitisuttithum Punnee⁵,Tran Ngoc H⁶,Bonaparte Matthew⁷,Chansinghakul Danaya⁸,Coronel Diana L⁹,L’Azou Maïna¹⁰,Ochiai R Leon¹⁰,Toh Myew-Ling¹¹,Noriega Fernando¹²,Bouckenooghe Alain¹³

Affiliation:

1. Dengue Company, Sanofi Pasteur, Lyon, France

2. Clinical Development, Sanofi Pasteur, Marcy l'Etoile, France

3. Instituto Nacional de Pediatría, Unidad de Apoyo a la Investigación Clínica, Mexico City, Mexico

4. Clinical Epidemiology Unit, School of Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia

5. Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

6. Pasteur Institute, Ho Chi Minh City, Vietnam

7. Global Clinical Immunology Department, Sanofi Pasteur, Swiftwater, Pennsylvania

8. Clinical Sciences, Sanofi Pasteur, Bangkok, Thailand

9. Clinical Sciences, Sanofi Pasteur, Mexico City

10. Global Epidemiology, Sanofi Pasteur, Lyon, France

11. Medical Affairs, Sanofi Pasteur, Lyon, France

12. Research and Development, Sanofi Pasteur, Swiftwater, Pennsylvania

13. Clinical Sciences, Sanofi Pasteur, Singapore

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/8/1164/25084824/cix966.pdf

Reference16 articles.

1. Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: utility for efficacy evaluation and impact of future vaccine introduction;Plennevaux;Vaccine,2016

2. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial;Sabchareon;Lancet,2012

3. Symptomatic dengue in children in 10 Asian and Latin American countries;L’Azou;N Engl J Med,2016

4. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial;Capeding;Lancet,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial;The American Journal of Tropical Medicine and Hygiene;2024-07-03

2. Dengue: A review of laboratory diagnostics in the vaccine age;Journal of Medical Microbiology;2024-05-09

3. Dengue Fever Epidemics and the Prospect of Vaccines: A Systematic Review and Meta-Analysis Using Clinical Trials in Children;Diseases;2024-02-06

4. Imported and autochthonous dengue in Spain;Revista Clínica Española (English Edition);2023-10

5. Dengue importado y autóctono en España;Revista Clínica Española;2023-10